Gutscheinbedingungen

*Gültig bis 05.07.2026 auf (fast) alles. Ausgeschlossen sind Smartboxen, Zeitschriften, Tickets, Lebensmittel, Gaming-Elektroartikel, Tinte/Toner, Gutscheine, Geschenkkarten, Blumen und Abos | Einlösbar in allen Buchhandlungen von Orell Füssli, Barth Bücher, Buchladen Rapunzel, Papeterie Köhler, Schuler Orell Füssli, Stauffacher und ZAP unter Vorweisung des Gutscheins, auf www.orellfüssli.ch durch Eingabe des Gutscheincodes. Beim Service „eBooks verschenken“ und bei eBook-Käufen via eReader nicht einlösbar | Mindesteinkaufswert: Fr. 30.- | Nicht mit anderen Rabatten kumulierbar.

Produktbild: Applications of Nanobiotechnology for Neglected Tropical Diseases

Applications of Nanobiotechnology for Neglected Tropical Diseases

Fr. 222.00

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

25.02.2021

Herausgeber

Fabio Rocha Formiga + weitere

Verlag

Elsevier Science & Technology

Seitenzahl

604

Maße (L/B)

22.9/15.2 cm

Gewicht

1070 g

Sprache

Englisch

ISBN

978-0-12-821100-7

Beschreibung

Portrait

Fabio Rocha Formiga graduated in pharmaceutical sciences, obtaining
his bachelor’s degree in 2004 from the Federal University of Rio Grande do
Norte, Brazil, where he also concluded a master’s course in health sciences.
In 2011, he obtained a PhD in pharmaceutical technology from the University
of Navarra in Spain, with distinctions, as a MAEC-AECID scholar. In 2018,
he completed a research training in nanobiomaterials at the Rice University
(Houston, United States). Dr. Formiga has worked as a visiting professor at
the University of Coimbra, Portugal. He has experience in teaching/supervision
at the BSc, MSc, and PhD levels. In addition, he has acted as referee for
national and foreign funding agencies. He has participated as a member of university
committees, examination boards, and has organized scientific meetings,
including the 22nd International Symposium on Microencapsulation (Chair).
Dr. Formiga has also been strongly involved in collaborative programs for exchange
with European universities (from Portugal, Spain, and Denmark). He is
a cofounder and vice-president of the Brazilian Chapter of Controlled Release
Society (CRS, 2019–present) and guest associate editor of the Drug Delivery
and Translational Research (Springer) and Pharmaceutical Nanotechnology
(Bentham). He is a member of the Brazilian Association of Pharmaceutical
Sciences (ABCF) and the European Foundation for Clinical Nanomedicine
(CLINAM). Currently, Dr. Formiga is a research scientist and deputy head of
the Department of Immunology at the Aggeu Magalhães Institute, Oswaldo
Cruz Foundation (FIOCRUZ), Brazil. He also holds a tenured adjunct professor
position at University of Pernambuco (UPE). Dr. Formiga was acknowledged
with the Research Award from Spanish Society of Pharmaceutics and
Pharmaceutical Technology (SEFIG) in 2013 and the Benjamin Gilbert Award
from FIOCRUZ in 2017. His research has focused on pharmaceutics, drug delivery,
nanotechnology, and biomaterials toward neglected tropical diseases and
regenerative medicine.

Dr. Inamuddin, is an Assistant professor at Department of Applied Chemistry, Zakir Husain College of Engineering and Technology, Faculty of Engineering and Technology, Aligarh Muslim University, Aligarh, India. He has extensive research experience in multidisciplinary fields of analytical chemistry, materials chemistry, electrochemistry, renewable energy and environmental science. He has worked on different research projects funded by various government agencies and universities and is the recipient of awards, including the Fast-Track Young Scientist Award and young researcher of the year award-2020 of the university. His current research interests include ion exchange materials, a sensor for heavy metal ions, biofuel cells, supercapacitors and bending actuators.

Dr. Severino is currently working as a professor in the College of Pharmacy
and Postgraduate Program in Industrial Biotechnology, Tiradentes University
(UNIT), Aracaju, Brazil and is also a research coordinator of Nanomedicine
and Nanotechnology Laboratory Institute of Technology and Research (ITP),
Aracaju, Brazil. She graduated in pharmacy from the Methodist University of
Piracicaba—Unimep (2005). She earned master’s and PhD from the Faculty
of Chemical Engineering at the State University of Campinas—Unicamp
(2008 and 2012). In the master's she carried out a sandwich program at the
Faculty of Pharmacy of the Federal University of Rio Grande do Sul—UFRGS
(2007–08), and in her PhD carried out a sandwich program at the Faculty of
Pharmacy of the Fernando Pessoa University—UFP, Porto, Portugal (2010–11).
She has extensive research experience in multidisciplinary fields of nanomedicine,
biomaterial, drug delivery, cosmetics, and biotechnology. She has
published
about 110 research articles in various international scientific journals,
24 book chapters, and 16 patents. She is a member of editorial boards of variousjournals. She has worked in technical-scientific collaboration with researchers
from different institutions in the country and abroad, such as the United States,
England, the Czech Republic, EUA, Italy, Turkey, India, and Portugal. She is a
CNPq research productivity scholar (PQ-2). Currently, she is working in the internationalization
process of UNIT at the Tiradentes Institute (TI-UMass) and is
a visiting professor at Brigham and Women’s Hospital/Harvard Medical School,
Cambridge, Massachusetts, United States.

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

25.02.2021

Herausgeber

Verlag

Elsevier Science & Technology

Seitenzahl

604

Maße (L/B)

22.9/15.2 cm

Gewicht

1070 g

Sprache

Englisch

ISBN

978-0-12-821100-7

EU-Ansprechpartner

Zeitfracht Medien GmbH
Ferdinand-Jühlke-Straße 7|99095|Erfurt|DE
produktsicherheit@zeitfracht.de

Herstelleradresse

Elsevier Science & Technology
125 London Wall|EC2Y 5AS|London|GB
tradeorders@elsevier.com

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

Die Leseprobe wird geladen.
  • Produktbild: Applications of Nanobiotechnology for Neglected Tropical Diseases
  • Part I: Nano-based approaches for prevention of NTD
    1. Experimental vaccination with nanoparticles containing Escherichia coli virulence factors
    2. Vaccine as immunotherapy for leishmaniasis
    3. Polymeric particles as a delivery agent for malarial vaccines

    Part II: Nano-Diagnostics and Detection of NTD
    4. The use of nano-enabled technologies to diagnose dengue virus infections
    5. Multiplexed detection with nanodiagnostics
    6. Nanosensor for the detection of malaria parasite

    Part III: Nanotherapeutics for NTD
    7. Developing effective amphotericin B delivery systems for fungal infections
    8. Development of nanocarriers for innovative antimalarial combination strategies
    9. Nanomedicines against Chagas disease
    10. Nanoformulations of old and new antimalarial drugs
    11. Drug repurposing and nanoparticles: New strategies against leishmaniasis
    12. Nanoformulations for new compounds against leishmaniasis
    13. Improving the miltefosine efficacy against leishmaniasis by using nanoassemblies made from surfactants or amphiphilic antimony (V) complex
    14. Trendings of amphotericin B-loaded nanoparticles as valuable chemotherapeutic approaches against leishmaniasis
    15. Nanopharmaceuticals to target antifilarials: Administration of old age drugs in a novel way
    16. Lipid nanoparticles for the treatment of neglected tropical diseases
    17. Experimental treatment of Schistosomiasis mansoni using praziquantel-free and encapsulated into nanostructures

    Part IV: Other approaches for NTD
    18. Bionanocomposite assembly with larvicidal activity against Aedes aegypti
    19. Microfilaricidal efficacy of silver nanoparticles
    20. Self-assembled nanocarriers as biotechnology approach to antivenom immunotherapy
    21. Novel processes combining natural products and synthetic materials for developing nanolarvicides
    22. Development of eco-friendly nano-mosquitocides against arboviruses vectors
    23. Systems biology and bioinformatics approaches in leishmaniasis
    24. May nanoparticles offer chances to avoid the development of insecticide resistance in mosquitoes?